Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
Ni, X.; Richardson, R. B.; de Godoy, A. S.; Ferla, M. P.; Kikawa, C.; Scheen, J.; Hannon, W. W.; Capkin, E.; Lahav, N.; Balcomb, B. H.; Marples, P. G.; Fairhead, M.; Wang, S.; Williams, E.; Tomlinson, C. W. E.; Aschenbrenner, J. C.; Lithgo, R.; Winokan, M.; Girould, C.; Chandran, A. V.; Walsh, M. A.; Thompson, W.; Bloom, J. D.; Barr, H.; Kirkegaard, K.; Koekemoer, L.; Fearon, D.; Evans, M. J.; von Delft, F.
Show abstract
The Zika viral protease NS2B-NS3 is essential for the cleavage of viral polyprotein precursor into individual structural and non-structural (NS) proteins and is therefore an attractive drug target. Generation of a robust crystal system of co-expressed NS2B-NS3 protease has enabled us to perform a crystallographic fragment screening campaign with 1076 fragments. 47 fragments with diverse scaffolds were identified to bind in the active site of the protease, with another 6 fragments observed in a potential allosteric site. To identify binding sites that are intolerant to mutation and thus suppress the outgrowth of viruses resistant to inhibitors developed from bound fragments, we performed deep mutational scanning of NS2B-NS3 protease. Merging fragment hits yields an extensive set of mergers, defined as synthetically accessible compounds that recapitulate constellations of observed fragment-protein interactions. In addition, the highly sociable fragment hits enable rapid exploration of chemical space via algorithmic calculation and thus yield diverse possible starting points that maximally explore the binding opportunities to NS2B-NS3 protease, facilitating its resistance-resilient antiviral development.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Molecular and structural mechanism of pan-genotypic HCV NS3/4A protease inhibition by glecaprevir 96%
- Integrative x-ray structure and molecular modeling for the rationalization of procaspase-8 inhibitor potency and selectivity 96%
- Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability 95%
Similar papers in this journal
Similar papers in this journal
- Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflavivirals 97%
- DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity 96%
- Discovery of a first-in-class small molecule ligand for WDR91 using DNA-encoded chemical library selection followed by machine learning 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.